يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Lactate dehydrogenase"', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: hemoglobinuria/dt [Drug Therapy], hemolytic anemia/co [Complication], hemolytic anemia/th [Therapy], human, intravascular hemolysis, lactate dehydrogenase blood level, letter, male, multiple myeloma/dt [Drug Therapy], priority journal, rosette formation, single drug dose, treatment duration, urine level, bilirubin/ec [Endogenous Compound], bortezomib/cb [Drug Combination], bortezomib/dt [Drug Therapy], complement component C3/ec [Endogenous Compound], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], eculizumab/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], hemosiderin/ec [Endogenous Compound], lactate dehydrogenase/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], thalidomide/cb [Drug Combination], thalidomide/dt [Drug Therapy], cold hemoglobinuria/co [Complication], cold hemoglobinuria/di [Diagnosis], cold hemoglobinuria/dr [Drug Resistance], cold hemoglobinuria/dt [Drug Therapy], hemoglobinuria/di [Diagnosis], adult, bilirubin blood level, cancer staging, case report, diagnostic test, disease severity, drug megadose, drug treatment failure, erythrocyte transfusion, erythrophagocytosis, hemoglobin blood level, hemoglobinuria/co [Complication], hemoglobinuria/dr [Drug Resistance], Letter

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30374Test
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: hemoglobinuria/dt [Drug Therapy], hemolytic anemia/co [Complication], hemolytic anemia/th [Therapy], human, intravascular hemolysis, lactate dehydrogenase blood level, letter, male, multiple myeloma/dt [Drug Therapy], priority journal, rosette formation, single drug dose, treatment duration, urine level, bilirubin/ec [Endogenous Compound], bortezomib/cb [Drug Combination], bortezomib/dt [Drug Therapy], complement component C3/ec [Endogenous Compound], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], eculizumab/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], hemosiderin/ec [Endogenous Compound], lactate dehydrogenase/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], thalidomide/cb [Drug Combination], thalidomide/dt [Drug Therapy], cold hemoglobinuria/co [Complication], cold hemoglobinuria/di [Diagnosis], cold hemoglobinuria/dr [Drug Resistance], cold hemoglobinuria/dt [Drug Therapy], hemoglobinuria/di [Diagnosis], adult, bilirubin blood level, cancer staging, case report, diagnostic test, disease severity, drug megadose, drug treatment failure, erythrocyte transfusion, erythrophagocytosis, hemoglobin blood level, hemoglobinuria/co [Complication], hemoglobinuria/dr [Drug Resistance], Letter

  3. 3
  4. 4